ArticleACS omega2026
ChemODE: A Physics-Informed Neural Surrogate for Robust Pharmacokinetics and Biochemical Dynamics.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The automated discovery of governing kinetic laws from observational data is a critical challenge in systems biology, pharmacology, and chemical engineering. In these experimental domains, data-driven mechanism discovery is complicated by sparse sampling, measurement noise (e.g., blood assays), and the prevalence of nonlinear saturation limits (Michaelis-Menten kinetics). Existing symbolic regression methods, such as SINDy, rely on polynomial basis functions that fundamentally fail to extrapolate physical saturation, and their reliance on numerical differentiation degrades catastrophically in high-noise regimes (>5%). In this work, we introduce ChemODE, a physics-informed gray-box framework tailored for biochemical and pharmacokinetic (PK) networks. ChemODE integrates (1) Constrained Rational Layers to autonomously enforce physical saturation laws, (2) On-the-fly Feature Normalization to resolve magnitude bias in multicompartment scale separations, and (3) a noise-robust integral-based optimization scheme. We validate ChemODE on fundamental biological benchmarks, including the nonlinear Brusselator limit cycle and a synthetic 3-compartment pharmacokinetic model. To demonstrate clinical applicability, ChemODE successfully extracts physiological absorption and elimination rates from real-world human theophylline pharmacokinetic assays. Furthermore, rigorous uncertainty quantification (10-seed ensembles) proves that ChemODE recovers enzyme kinetics with high precision (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.